HazemYacoub
@hazemyacoub.bsky.social
Mobile manufacturing units have the potential to strengthen supply chain flexibility, but are they feasible for oral solid dosages?
The smaller physical footprints of continuous OSD technologies make adapting to mobile manufacturing much simpler than other formulations.
The smaller physical footprints of continuous OSD technologies make adapting to mobile manufacturing much simpler than other formulations.
November 10, 2025 at 6:55 AM
Mobile manufacturing units have the potential to strengthen supply chain flexibility, but are they feasible for oral solid dosages?
The smaller physical footprints of continuous OSD technologies make adapting to mobile manufacturing much simpler than other formulations.
The smaller physical footprints of continuous OSD technologies make adapting to mobile manufacturing much simpler than other formulations.
India will be one of the earliest markets to face LoE for Semaglutide, but taking advantage will require generics companies to adapt their LoE playbooks.
Source: https://www.iqvia.com/locations/india/blogs/2025/10/semaglutide-loe-in-india-a-rare-opportunity-demanding-a-new-playbook
Source: https://www.iqvia.com/locations/india/blogs/2025/10/semaglutide-loe-in-india-a-rare-opportunity-demanding-a-new-playbook
November 5, 2025 at 9:02 AM
India will be one of the earliest markets to face LoE for Semaglutide, but taking advantage will require generics companies to adapt their LoE playbooks.
Source: https://www.iqvia.com/locations/india/blogs/2025/10/semaglutide-loe-in-india-a-rare-opportunity-demanding-a-new-playbook
Source: https://www.iqvia.com/locations/india/blogs/2025/10/semaglutide-loe-in-india-a-rare-opportunity-demanding-a-new-playbook
Challenging patents can be a powerful way for generics companies to open up the market, but litigation isn't the only approach they can take.
A blend of both litigation and negotiation can help reduce costs and create a degree of certainty that litigation alone cannot provide.
A blend of both litigation and negotiation can help reduce costs and create a degree of certainty that litigation alone cannot provide.
November 3, 2025 at 7:18 AM
Challenging patents can be a powerful way for generics companies to open up the market, but litigation isn't the only approach they can take.
A blend of both litigation and negotiation can help reduce costs and create a degree of certainty that litigation alone cannot provide.
A blend of both litigation and negotiation can help reduce costs and create a degree of certainty that litigation alone cannot provide.
Chronic diseases are on the rise in the MENA region, which is fuelling the expansion of clinical trials. With this expansion comes more locally relevant clinical data, allowing drug developers to identify unmet medical needs and explore ways to translate these into pharmaceutical opportunity.
October 29, 2025 at 5:57 AM
Chronic diseases are on the rise in the MENA region, which is fuelling the expansion of clinical trials. With this expansion comes more locally relevant clinical data, allowing drug developers to identify unmet medical needs and explore ways to translate these into pharmaceutical opportunity.
The market for simple oral solids is oversaturated, but there are still plenty of opportunities in more complex OSDs. By perfecting complex generics, manufacturers can escape the intense price pressure traditionally associated with OSDs while still delivering convenient dosage forms for patients.
October 24, 2025 at 7:53 AM
The market for simple oral solids is oversaturated, but there are still plenty of opportunities in more complex OSDs. By perfecting complex generics, manufacturers can escape the intense price pressure traditionally associated with OSDs while still delivering convenient dosage forms for patients.
North American drug manufacturers are using AI to enhance the manufacturing process and boost resilience during a time of uncertainty, which raises the question: could AI be the key to strengthening the global industry against disruption?
October 17, 2025 at 7:41 AM
North American drug manufacturers are using AI to enhance the manufacturing process and boost resilience during a time of uncertainty, which raises the question: could AI be the key to strengthening the global industry against disruption?
In drug manufacturing, control and consistency matter.
But as drugs get more complex, maintaining this using traditional methods becomes more difficult, and companies may find themselves struggling with yield losses.
But AI-enabled digital twins could be the key to eliminating these issues.
But as drugs get more complex, maintaining this using traditional methods becomes more difficult, and companies may find themselves struggling with yield losses.
But AI-enabled digital twins could be the key to eliminating these issues.
October 15, 2025 at 9:00 AM
In drug manufacturing, control and consistency matter.
But as drugs get more complex, maintaining this using traditional methods becomes more difficult, and companies may find themselves struggling with yield losses.
But AI-enabled digital twins could be the key to eliminating these issues.
But as drugs get more complex, maintaining this using traditional methods becomes more difficult, and companies may find themselves struggling with yield losses.
But AI-enabled digital twins could be the key to eliminating these issues.
Solid tablets are popular, but for children, the elderly, and disabled patients, they can be difficult to swallow
Fast-melt tablets are helping to eliminate that problem, and pharma companies that embrace them are finding new opportunities to capture greater market share.
Fast-melt tablets are helping to eliminate that problem, and pharma companies that embrace them are finding new opportunities to capture greater market share.
October 8, 2025 at 9:04 AM
Solid tablets are popular, but for children, the elderly, and disabled patients, they can be difficult to swallow
Fast-melt tablets are helping to eliminate that problem, and pharma companies that embrace them are finding new opportunities to capture greater market share.
Fast-melt tablets are helping to eliminate that problem, and pharma companies that embrace them are finding new opportunities to capture greater market share.
#OralSolidDosage manufacturing is complicated.
But instead of turning to other #DosageForms, manufacturers are enlisting the help of #CDMOs—and it's starting to pay off.
Source: https://uk.finance.yahoo.com/news/oral-solid-dosage-manufacturing-market-081500236.html
#Pharma
But instead of turning to other #DosageForms, manufacturers are enlisting the help of #CDMOs—and it's starting to pay off.
Source: https://uk.finance.yahoo.com/news/oral-solid-dosage-manufacturing-market-081500236.html
#Pharma
October 1, 2025 at 5:56 AM
#OralSolidDosage manufacturing is complicated.
But instead of turning to other #DosageForms, manufacturers are enlisting the help of #CDMOs—and it's starting to pay off.
Source: https://uk.finance.yahoo.com/news/oral-solid-dosage-manufacturing-market-081500236.html
#Pharma
But instead of turning to other #DosageForms, manufacturers are enlisting the help of #CDMOs—and it's starting to pay off.
Source: https://uk.finance.yahoo.com/news/oral-solid-dosage-manufacturing-market-081500236.html
#Pharma
Slow and steady wins the race.
As #OralSolids manufacturers prioritize speed to clinic, they can't afford to forget the importance of front-loaded #RiskIdentification. The earlier you spot a compound's red flags, the easier it is to work around them.
#DrugDevelopment
As #OralSolids manufacturers prioritize speed to clinic, they can't afford to forget the importance of front-loaded #RiskIdentification. The earlier you spot a compound's red flags, the easier it is to work around them.
#DrugDevelopment
September 29, 2025 at 7:57 AM
Slow and steady wins the race.
As #OralSolids manufacturers prioritize speed to clinic, they can't afford to forget the importance of front-loaded #RiskIdentification. The earlier you spot a compound's red flags, the easier it is to work around them.
#DrugDevelopment
As #OralSolids manufacturers prioritize speed to clinic, they can't afford to forget the importance of front-loaded #RiskIdentification. The earlier you spot a compound's red flags, the easier it is to work around them.
#DrugDevelopment
How do you develop an #OralSolidDosage form for a poorly soluble drug?
Despite technological advancements, this challenge remains a key barrier in #DrugDevelopment. However, that could soon change. By using AI to identify potential formulations, we may be able to speed up the process.
#Pharma
Despite technological advancements, this challenge remains a key barrier in #DrugDevelopment. However, that could soon change. By using AI to identify potential formulations, we may be able to speed up the process.
#Pharma
September 24, 2025 at 6:53 AM
How do you develop an #OralSolidDosage form for a poorly soluble drug?
Despite technological advancements, this challenge remains a key barrier in #DrugDevelopment. However, that could soon change. By using AI to identify potential formulations, we may be able to speed up the process.
#Pharma
Despite technological advancements, this challenge remains a key barrier in #DrugDevelopment. However, that could soon change. By using AI to identify potential formulations, we may be able to speed up the process.
#Pharma
The global #pharma market is set to grow at a CAGR of 7.7% until 2033, making this an excellent time for companies to invest in their own growth.
For companies looking to expand into new markets, #Europe offers a stable and resilient market thanks to its mature health systems.
#GlobalStrategy
For companies looking to expand into new markets, #Europe offers a stable and resilient market thanks to its mature health systems.
#GlobalStrategy
September 19, 2025 at 8:08 AM
The global #pharma market is set to grow at a CAGR of 7.7% until 2033, making this an excellent time for companies to invest in their own growth.
For companies looking to expand into new markets, #Europe offers a stable and resilient market thanks to its mature health systems.
#GlobalStrategy
For companies looking to expand into new markets, #Europe offers a stable and resilient market thanks to its mature health systems.
#GlobalStrategy
Highly potent APIs don't come without risk. The need to avoid operator exposure and environmental and cross-contamination when handling these ingredients is only making #OralSolidDosage manufacturing more difficult.
Could investing in AI and IoT-powered contamination control be the solution?
Could investing in AI and IoT-powered contamination control be the solution?
September 17, 2025 at 9:01 AM
Highly potent APIs don't come without risk. The need to avoid operator exposure and environmental and cross-contamination when handling these ingredients is only making #OralSolidDosage manufacturing more difficult.
Could investing in AI and IoT-powered contamination control be the solution?
Could investing in AI and IoT-powered contamination control be the solution?
Did you know that #OralSolids account for 88% of all oral drug delivery?
Innovation in controlled-release formulations is helping to sustain this dominance, creating new opportunities for smaller firms to leave their mark on the market at the same time.
#MarketTrends #Pharmaceuticals
Innovation in controlled-release formulations is helping to sustain this dominance, creating new opportunities for smaller firms to leave their mark on the market at the same time.
#MarketTrends #Pharmaceuticals
September 12, 2025 at 8:25 AM
Did you know that #OralSolids account for 88% of all oral drug delivery?
Innovation in controlled-release formulations is helping to sustain this dominance, creating new opportunities for smaller firms to leave their mark on the market at the same time.
#MarketTrends #Pharmaceuticals
Innovation in controlled-release formulations is helping to sustain this dominance, creating new opportunities for smaller firms to leave their mark on the market at the same time.
#MarketTrends #Pharmaceuticals
#ContinuousManufacturing is at the very heart of #OralSolids manufacturing, but that doesn't change the fact that it's complex.
The integration of #AI and machine learning tools will help ease some of these challenges, paving the way for greater efficiency and improved product quality.
#Pharma
The integration of #AI and machine learning tools will help ease some of these challenges, paving the way for greater efficiency and improved product quality.
#Pharma
September 8, 2025 at 6:17 AM
#ContinuousManufacturing is at the very heart of #OralSolids manufacturing, but that doesn't change the fact that it's complex.
The integration of #AI and machine learning tools will help ease some of these challenges, paving the way for greater efficiency and improved product quality.
#Pharma
The integration of #AI and machine learning tools will help ease some of these challenges, paving the way for greater efficiency and improved product quality.
#Pharma
Imagine being able to cut #capsule production costs by 35%.
#3DPrinting technology could soon make that possible without forcing companies to sacrifice quality or effectiveness.
Source: https://3dprint.com/316650/new-fabrx-study-says-3d-printed-pills-cuts-costs-by-35/
#FutureOfPharma
#3DPrinting technology could soon make that possible without forcing companies to sacrifice quality or effectiveness.
Source: https://3dprint.com/316650/new-fabrx-study-says-3d-printed-pills-cuts-costs-by-35/
#FutureOfPharma
September 5, 2025 at 8:33 AM
Imagine being able to cut #capsule production costs by 35%.
#3DPrinting technology could soon make that possible without forcing companies to sacrifice quality or effectiveness.
Source: https://3dprint.com/316650/new-fabrx-study-says-3d-printed-pills-cuts-costs-by-35/
#FutureOfPharma
#3DPrinting technology could soon make that possible without forcing companies to sacrifice quality or effectiveness.
Source: https://3dprint.com/316650/new-fabrx-study-says-3d-printed-pills-cuts-costs-by-35/
#FutureOfPharma
60% of #APIs are inherently bitter, contributing to poor treatment adherence among patients.
By investing in flavoring and formulation innovation, #OralSolids manufacturers can be part of the solution and differentiate themselves from the competition all at once.
#Pharma #PharmaManufacturing
By investing in flavoring and formulation innovation, #OralSolids manufacturers can be part of the solution and differentiate themselves from the competition all at once.
#Pharma #PharmaManufacturing
September 3, 2025 at 7:05 AM
60% of #APIs are inherently bitter, contributing to poor treatment adherence among patients.
By investing in flavoring and formulation innovation, #OralSolids manufacturers can be part of the solution and differentiate themselves from the competition all at once.
#Pharma #PharmaManufacturing
By investing in flavoring and formulation innovation, #OralSolids manufacturers can be part of the solution and differentiate themselves from the competition all at once.
#Pharma #PharmaManufacturing
Success in the European #pharma market doesn't just depend on innovation; it also depends on #quality.
Streamlining your R&D processes can help eliminate inefficiencies and address quality concerns, setting the stage for a successful drug launch when the time comes.
#QualityControl #Europe
Streamlining your R&D processes can help eliminate inefficiencies and address quality concerns, setting the stage for a successful drug launch when the time comes.
#QualityControl #Europe
August 29, 2025 at 7:41 AM
Success in the European #pharma market doesn't just depend on innovation; it also depends on #quality.
Streamlining your R&D processes can help eliminate inefficiencies and address quality concerns, setting the stage for a successful drug launch when the time comes.
#QualityControl #Europe
Streamlining your R&D processes can help eliminate inefficiencies and address quality concerns, setting the stage for a successful drug launch when the time comes.
#QualityControl #Europe
#Generics opportunities don't have to be generic in value. By observing how disease patterns in #EmergingMarkets are changing, generics manufacturers can identify untapped opportunities that can give them an edge as they expand into new markets.
#Pharma
#Pharma
August 18, 2025 at 7:47 AM
#Generics opportunities don't have to be generic in value. By observing how disease patterns in #EmergingMarkets are changing, generics manufacturers can identify untapped opportunities that can give them an edge as they expand into new markets.
#Pharma
#Pharma
In the debate between branded and generic drugs, could #BrandedGenerics come out on top?
Giving proprietary brand names to #generics creates a unique opportunity to differentiate a drug from its generic competition, especially in highly competitive markets.
#Pharma
Giving proprietary brand names to #generics creates a unique opportunity to differentiate a drug from its generic competition, especially in highly competitive markets.
#Pharma
August 15, 2025 at 6:17 AM
In the debate between branded and generic drugs, could #BrandedGenerics come out on top?
Giving proprietary brand names to #generics creates a unique opportunity to differentiate a drug from its generic competition, especially in highly competitive markets.
#Pharma
Giving proprietary brand names to #generics creates a unique opportunity to differentiate a drug from its generic competition, especially in highly competitive markets.
#Pharma
The global ethical pharmaceuticals market is growing.
#EmergingMarkets offer a great opportunity to get in on the hype thanks to growing demand in these regions.
Source: https://www.globalgrowthinsights.com/market-reports/ethical-pharmaceuticals-market-118049
#Pharma #MarketExpansion
#EmergingMarkets offer a great opportunity to get in on the hype thanks to growing demand in these regions.
Source: https://www.globalgrowthinsights.com/market-reports/ethical-pharmaceuticals-market-118049
#Pharma #MarketExpansion
August 6, 2025 at 7:16 AM
The global ethical pharmaceuticals market is growing.
#EmergingMarkets offer a great opportunity to get in on the hype thanks to growing demand in these regions.
Source: https://www.globalgrowthinsights.com/market-reports/ethical-pharmaceuticals-market-118049
#Pharma #MarketExpansion
#EmergingMarkets offer a great opportunity to get in on the hype thanks to growing demand in these regions.
Source: https://www.globalgrowthinsights.com/market-reports/ethical-pharmaceuticals-market-118049
#Pharma #MarketExpansion
A new era of #patent processes is here.
The UAE and the US Joint Statement of Intent will see the creation of a framework that allows the UAE to recognize positive examination results issued by the USPTO, paving the way for faster approvals.
#Pharma #IP
The UAE and the US Joint Statement of Intent will see the creation of a framework that allows the UAE to recognize positive examination results issued by the USPTO, paving the way for faster approvals.
#Pharma #IP
August 4, 2025 at 8:38 AM
A new era of #patent processes is here.
The UAE and the US Joint Statement of Intent will see the creation of a framework that allows the UAE to recognize positive examination results issued by the USPTO, paving the way for faster approvals.
#Pharma #IP
The UAE and the US Joint Statement of Intent will see the creation of a framework that allows the UAE to recognize positive examination results issued by the USPTO, paving the way for faster approvals.
#Pharma #IP
As one-stop-shop CDMOs become more popular in #pharma, it's getting harder and harder to differentiate yourself. Is #specialization the solution?
By pursuing mastery in a niche area, you can cater to the unique needs of clients who aren't a good fit for full-service CDMOs.
#CDMO
By pursuing mastery in a niche area, you can cater to the unique needs of clients who aren't a good fit for full-service CDMOs.
#CDMO
July 30, 2025 at 7:07 AM
As one-stop-shop CDMOs become more popular in #pharma, it's getting harder and harder to differentiate yourself. Is #specialization the solution?
By pursuing mastery in a niche area, you can cater to the unique needs of clients who aren't a good fit for full-service CDMOs.
#CDMO
By pursuing mastery in a niche area, you can cater to the unique needs of clients who aren't a good fit for full-service CDMOs.
#CDMO
Pharma in MENA still leans on outdated models: full-stack companies doing it all. Globally, the value chain is split. CMOs, developers, marketers, distributors. each to their niche
It's time we embrace specialization over duplication
Smarter models, Leaner ops, Greater access
#Pharma #CDMO #PiPharma
It's time we embrace specialization over duplication
Smarter models, Leaner ops, Greater access
#Pharma #CDMO #PiPharma
July 23, 2025 at 7:18 AM
Pharma in MENA still leans on outdated models: full-stack companies doing it all. Globally, the value chain is split. CMOs, developers, marketers, distributors. each to their niche
It's time we embrace specialization over duplication
Smarter models, Leaner ops, Greater access
#Pharma #CDMO #PiPharma
It's time we embrace specialization over duplication
Smarter models, Leaner ops, Greater access
#Pharma #CDMO #PiPharma
Knowledge is power. Especially when it comes to financial security.
We hosted an employee session with the Social Security Corporation & TechWIN to strengthen awareness of rights and benefits under the Social Security Law
Empowering our team is a priority.
#PiPharma #EmployeeWellbeing #PharmaCareers
We hosted an employee session with the Social Security Corporation & TechWIN to strengthen awareness of rights and benefits under the Social Security Law
Empowering our team is a priority.
#PiPharma #EmployeeWellbeing #PharmaCareers
July 21, 2025 at 7:15 AM
Knowledge is power. Especially when it comes to financial security.
We hosted an employee session with the Social Security Corporation & TechWIN to strengthen awareness of rights and benefits under the Social Security Law
Empowering our team is a priority.
#PiPharma #EmployeeWellbeing #PharmaCareers
We hosted an employee session with the Social Security Corporation & TechWIN to strengthen awareness of rights and benefits under the Social Security Law
Empowering our team is a priority.
#PiPharma #EmployeeWellbeing #PharmaCareers